Breast cancer patients enrolled in the Swiss mammography screening program "donna" demonstrate prolonged survival.

Women participating in the "donna" MSP had a significantly higher overall and BC related survival rate than women outside the program. Detection of BC at an earlier tumor stage only partially explains the observed differences.